Bendell J - Search Results

1

Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.

André T, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, Smith D, Garcia-Carbonero R, Benavides M, Gibbs P, de la Fouchardiere C, Rivera F, Elez E, Bendell J, Le DT, Yoshino T, Van Cutsem E, Yang P, Farooqui MZH, Marinello P, Diaz LA Jr; KEYNOTE-177 Investigators. André T, et al. Among authors: bendell j. N Engl J Med. 2020 Dec 3;383(23):2207-2218. doi: 10.1056/NEJMoa2017699. N Engl J Med. 2020. PMID: 33264544 Free article. Clinical Trial.

2

Paclitaxel-based chemoradiotherapy in the treatment of patients with operable esophageal cancer.

Kelsey CR, Chino JP, Willett CG, Clough RW, Hurwitz HI, Morse MA, Bendell JC, D'Amico TA, Czito BG. Kelsey CR, et al. Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):770-6. doi: 10.1016/j.ijrobp.2007.03.035. Int J Radiat Oncol Biol Phys. 2007. PMID: 17889266

3

Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases.

Reddy SK, Morse MA, Hurwitz HI, Bendell JC, Gan TJ, Hill SE, Clary BM. Reddy SK, et al. Among authors: bendell jc. J Am Coll Surg. 2008 Jan;206(1):96-106. doi: 10.1016/j.jamcollsurg.2007.06.290. Epub 2007 Sep 17. J Am Coll Surg. 2008. PMID: 18155574

4

Multiagent chemotherapy for isolated colorectal liver metastases: a single-centered retrospective study.

Reddy SK, Broadwater G, Niedzwiecki D, Barbas AS, Hurwitz HI, Bendell JC, Morse MA, Clary BM. Reddy SK, et al. J Gastrointest Surg. 2009 Jan;13(1):74-84. doi: 10.1007/s11605-008-0617-5. Epub 2008 Aug 7. J Gastrointest Surg. 2009. PMID: 18685900

5

Phase II trial of FOLFOX6, bevacizumab, and cetuximab in the first-line treatment of metastatic colorectal cancer.

Spigel DR, Greco FA, Waterhouse D, Shipley D, Lane CM, Vazquez ER, Clark BL, Infante JR, Bendell JC, Burris HA 3rd, Hainsworth JD. Spigel DR, et al. Clin Adv Hematol Oncol. 2010 Jul;8(7):480-5, 498. Clin Adv Hematol Oncol. 2010. PMID: 20864916 Clinical Trial.

6

A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancer.

Wong NS, Fernando NH, Nixon AB, Cushman S, Aklilu M, Bendell JC, Morse MA, Blobe GC, Ashton J, Pang H, Hurwitz HI. Wong NS, et al. Among authors: bendell jc. Anticancer Res. 2011 Jan;31(1):255-61. Anticancer Res. 2011. PMID: 21273607 Free PMC article. Clinical Trial.

7

A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer.

Altomare I, Bendell JC, Bullock KE, Uronis HE, Morse MA, Hsu SD, Zafar SY, Blobe GC, Pang H, Honeycutt W, Sutton L, Hurwitz HI. Altomare I, et al. Oncologist. 2011;16(8):1131-7. doi: 10.1634/theoncologist.2011-0078. Epub 2011 Jul 27. Oncologist. 2011. PMID: 21795432 Free PMC article. Clinical Trial.

8

A phase II study of oxaliplatin, dose-intense capecitabine, and high-dose bevacizumab in the treatment of metastatic colorectal cancer.

Wong NS, Fernando NH, Bendell JC, Morse MA, Blobe GC, Honeycutt W, Pang H, Hurwitz HI. Wong NS, et al. Clin Colorectal Cancer. 2011 Sep;10(3):210-6. doi: 10.1016/j.clcc.2011.03.018. Epub 2011 Apr 24. Clin Colorectal Cancer. 2011. PMID: 21855046 Free PMC article. Clinical Trial.

9

Randomized placebo-controlled phase II trial of perifosine plus capecitabine as second- or third-line therapy in patients with metastatic colorectal cancer.

Bendell JC, Nemunaitis J, Vukelja SJ, Hagenstad C, Campos LT, Hermann RC, Sportelli P, Gardner L, Richards DA. Bendell JC, et al. J Clin Oncol. 2011 Nov 20;29(33):4394-400. doi: 10.1200/JCO.2011.36.1980. Epub 2011 Oct 3. J Clin Oncol. 2011. PMID: 21969495 Clinical Trial.

10

Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-bevacizumab or FOLFIRI-bevacizumab: results from ARIES, a bevacizumab observational cohort study.

Bendell JC, Bekaii-Saab TS, Cohn AL, Hurwitz HI, Kozloff M, Tezcan H, Roach N, Mun Y, Fish S, Flick ED, Dalal D, Grothey A. Bendell JC, et al. Oncologist. 2012;17(12):1486-95. doi: 10.1634/theoncologist.2012-0190. Epub 2012 Sep 26. Oncologist. 2012. PMID: 23015662 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

241 results

Search Page